| NASDAQ (usa) |
|
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
![]() |
7487.96 | -5.12 | -0.07% |
| DAX (german) |
|
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
BriaCell Therapeutics Corp (NASDAQ: BCTXW)
BCTXW Technical Analysis
5
| As on 13th Feb 2026 BCTXW STOCK Price closed @ 0.00 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 0.10 & Strong Sell for SHORT-TERM with Stoploss of 0.21 we also expect STOCK to react on Following IMPORTANT LEVELS. |
BCTXWSTOCK Price
| Open | 0.00 | Change | Price | % |
| High | 0.01 | 1 Day | -0.01 | -100.00 |
| Low | 0.00 | 1 Week | -0.01 | -100.00 |
| Close | 0.00 | 1 Month | -0.05 | -100.00 |
| Volume | 10305 | 1 Year | -0.43 | -100.00 |
| 52 Week High 0.54 | 52 Week Low 0.00 | ||||
NASDAQ USA Most Active Stocks
| LPTX | 2.05 | 365.91% |
| AMRS | 0.14 | 100.00% |
| WBA | 11.98 | 0.50% |
| NVDA | 182.81 | -2.21% |
| LMDX | 0.02 | 0.00% |
| YGMZ | 0.02 | -66.67% |
| PLUG | 1.89 | 3.85% |
| LILM | 0.05 | 0.00% |
| PONO | 1.72 | 2.38% |
| TELL | 1.00 | 0.00% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
| BCTXW Daily Charts |
BCTXW Intraday Charts |
Whats New @ Bazaartrend |
BCTXW Free Analysis |
|
|
BCTXW Important Levels Intraday
| RESISTANCE | 0.02 |
| RESISTANCE | 0.01 |
| RESISTANCE | 0.01 |
| RESISTANCE | 0.01 |
| SUPPORT | -0.01 |
| SUPPORT | -0.01 |
| SUPPORT | -0.01 |
| SUPPORT | -0.02 |
BCTXW Forecast February 2026
| 4th UP Forecast | 0.39 |
| 3rd UP Forecast | 0.26 |
| 2nd UP Forecast | 0.19 |
| 1st UP Forecast | 0.11 |
| 1st DOWN Forecast | -0.11 |
| 2nd DOWN Forecast | -0.19 |
| 3rd DOWN Forecast | -0.26 |
| 4th DOWN Forecast | -0.39 |
BCTXW Weekly Forecast
| 4th UP Forecast | 0.69 |
| 3rd UP Forecast | 0.47 |
| 2nd UP Forecast | 0.33 |
| 1st UP Forecast | 0.20 |
| 1st DOWN Forecast | -0.20 |
| 2nd DOWN Forecast | -0.33 |
| 3rd DOWN Forecast | -0.47 |
| 4th DOWN Forecast | -0.69 |
BCTXW Forecast2026
| 4th UP Forecast | 1.35 |
| 3rd UP Forecast | 0.92 |
| 2nd UP Forecast | 0.65 |
| 1st UP Forecast | 0.38 |
| 1st DOWN Forecast | -0.38 |
| 2nd DOWN Forecast | -0.65 |
| 3rd DOWN Forecast | -0.92 |
| 4th DOWN Forecast | -1.35 |
BriaCell Therapeutics Corp ( NASDAQ USA Symbol : BCTXW )
Sector : N/A And Other Stocks in Same Sector
Sector : N/A And Other Stocks in Same Sector
BCTXW Other Details
| Segment | EQ | |
| Market Capital | 48083940.00 | |
| Sector | ||
| Industry | ||
| Offical website | > echo $website ; ?> | |
BCTXW Address
![]() |
||
BCTXW Latest News
BCTXW Business Profile
BriaCell Therapeutics Corp., an immuno-oncology biotechnology company, engages in developing approaches for the management of cancer. Its lead candidate is Bria-IMT that is in Phase I/IIa clinical trial in a combination study with immune checkpoint inhibitors for the treatment of breast cancer. The company also has a cooperative research and development agreement with the National Cancer Institute for developing Bria-OTS, an off-the-shelf personalized immunotherapy for advanced breast cancer; and BriaDx, a diagnostic test. BriaCell Therapeutics Corp. is headquartered in West Vancouver, Canada. Address: Bellevue Centre, West Vancouver, BC, Canada, V7T 2X1
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service

